Your browser doesn't support javascript.
loading
Isoliquiritigenin attenuates oxidative hepatic damage induced by carbon tetrachloride with or without buthionine sulfoximine.
Zhao, ZhengLin; Park, Sang Mi; Guan, LiXin; Wu, YiYan; Lee, Jong Rok; Kim, Sang Chan; Kim, Young Woo; Zhao, RongJie.
Afiliação
  • Zhao Z; College of Oriental Medicine, Daegu Haany University, Daegu 706-828, Republic of Korea; Department of Pharmacology, Mudanjiang Medical University, Heilongjiang 157011, China.
  • Park SM; College of Oriental Medicine, Daegu Haany University, Daegu 706-828, Republic of Korea.
  • Guan L; Department of Pharmacology, Mudanjiang Medical University, Heilongjiang 157011, China.
  • Wu Y; Department of Pharmacology, Mudanjiang Medical University, Heilongjiang 157011, China.
  • Lee JR; College of Oriental Medicine, Daegu Haany University, Daegu 706-828, Republic of Korea.
  • Kim SC; College of Oriental Medicine, Daegu Haany University, Daegu 706-828, Republic of Korea. Electronic address: sckim@dhu.ac.kr.
  • Kim YW; College of Oriental Medicine, Daegu Haany University, Daegu 706-828, Republic of Korea. Electronic address: ywkim@dhu.ac.kr.
  • Zhao R; College of Oriental Medicine, Daegu Haany University, Daegu 706-828, Republic of Korea; Department of Pharmacology, Mudanjiang Medical University, Heilongjiang 157011, China. Electronic address: zhao_rongjie@yahoo.com.
Chem Biol Interact ; 225: 13-20, 2015 Jan 05.
Article em En | MEDLINE | ID: mdl-25450236
ABSTRACT
Glycyrrhizae radix (G. radix) has been demonstrated to have hepatoprotective properties. This study determined the therapeutic effects of isoliquiritigenin (isoLQ) in G. radix, against liver injury induced by CCl4 in rats. CCl4 (0.5 ml/kg/d, twice) or CCl4 plus buthionine sulfoximine exerted severe liver damage assessed by increased plasma levels of alanine aminotransferase and aspartate aminotransferase, in addition to hepatic degeneration and necrosis. These pathological changes were markedly protected by pretreatment with isoLQ (5, 20 mg/kg/d, p.o.) for 3 consecutive days. In addition, pretreatment with isoLQ inhibited CCl4-induced reduction of cytochrome P450 2E1 protein and mRNA expression as well as activity in the liver. Moreover, isoLQ pretreatment reversed the decrease in hepatic antioxidant capacity induced by CCl4 as well as suppressed expression of tumor necrosis factor-alpha and cyclooxigenase-2 in the liver. These results suggest that isoLQ has a protective effect against CCl4-induced liver damage through induction of antioxidant and anti-inflammatory activities.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetracloreto de Carbono / Citocromo P-450 CYP2E1 / Butionina Sulfoximina / Chalconas / Inibidores Enzimáticos / Doença Hepática Induzida por Substâncias e Drogas Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetracloreto de Carbono / Citocromo P-450 CYP2E1 / Butionina Sulfoximina / Chalconas / Inibidores Enzimáticos / Doença Hepática Induzida por Substâncias e Drogas Idioma: En Ano de publicação: 2015 Tipo de documento: Article